E-Learning

Apple, Tesla downgraded: Wall Street's top analyst calls

On Tuesday, Immuneering Corporation (NASDAQ:IMRX) revealed data updates from three pancreatic cancer arms of its ongoing Phase 2a trial of lead program IMM-1-104 and plans to expand the Phase 2a trial to include three additional combination arms. Updated data from the Phase 2a arm of IMM-1-104 with modified gemcitabine/nab-paclitaxel in first-line pancreatic cancer shows: As of December 5, 2024, three patients achieved complete or partial responses for an overall response rate of 43% (3/7) and a

RPM International Inc (NYSE:RPM) shares are trading lower after the company reported second-quarter results. Sales increased 3% year over year to $1.845 billion, beating the consensus of $1.789 billion. Sales growth was driven by higher volumes across segments and strong performance in technical solutions. Geographically, sales growth was strong in North America, mixed elsewhere, with Europe improving profitability, while Latin America and Asia declined. Adjusted EPS was $1.39, beating the conse

Aurora Innovation (AUR) stock was booming early Tuesday after the company’s latest partnership was revealed during Nvidia CEO Jensen Huang’s Consumer Electronics Show (CES) keynote on Monday.

Mercedes-Benz will lower mid-term profitability targets for its passenger car business due to prolonged weakness in the market and the switch to electric-powered vehicles, a source familiar with the matter told Reuters on Tuesday. The German premium automaker's management board, led by CEO Ola Kaellenius, will revise downwards the targets it set in 2022 by Feb. 20, when the company plans to hold its capital markets day, the source said. In the best-case scenario, Mercedes will aim for profitability in a double-digit margin, the source added.

The sale comes as a Morgan Stanley analyst cautioned that Palantir is “trading too far ahead” of its intrinsic value as it looks to take advantage of the generative AI boom.

Gold Resource Corporation (AMEX:GORO) shares declined premarket on Tuesday after the company disclosed a registered direct offering of up to 15.63 million shares at $0.16 per share. The company aims to raise approximately $2.5 million. The offering is expected to close within 10 days, pending customary conditions. Last month, Gold Resource provided an update on its operations and liquidity, noting improved production at the Don David Gold Mine in November compared to earlier in the fourth quarte

Citigroup Inc. (NYSE:C) will release its fourth-quarter financial results before the opening bell on Wednesday, Jan. 15. Analysts expect the New York-based company to report quarterly earnings at $1.21 per share, up from 84 cents per share in the year-ago period. Citigroup projects quarterly revenue of $19.42 billion, compared to $17.44 billion a year earlier, according to data from Benzinga Pro. On Monday, Barclays upgraded the stock from Equal-Weight to Overweight and raised its price target f

The tech giant announced several new products at the CES trade show in Las Vegas on Monday, including its first desktop computer.

CERo Therapeutics (CERO) announced that its board of directors has determined to effect a one-for-one hundred reverse stock split of the Company’s common stock, par value $0.0001 per share. The reverse stock split will take effect at 12:01 a.m. Eastern Time on January 8, 2025, and the Company’s Common Stock will begin trading on a split-adjusted basis on The Nasdaq Global Market as of the opening of trading on January 8, 2025. The CUSIP number of 71902K303 will be assigned to the Company’s Commo